What's in Jung-min Ahn's pipeline?

Jung-min Ahn has 3 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Jung-min Ahn's portfolio?

Top competitors by shared drug class: AstraZeneca, Beijing Tiantan Hospital, Chong Kun Dang Pharmaceutical, Daewoong Pharmaceutical Co. LTD., Dong-A ST Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/jung-min-ahn.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Jung-min Ahn — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Jung-min Ahn pipeline: 3 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Aspirin only	Aspirin only	marketed
No antiplatelet therapy	No antiplatelet therapy	marketed
High-intensity statin	High-intensity statin	marketed	HMG-CoA reductase inhibitor (statin)	HMG-CoA reductase	Cardiovascular

Therapeutic area mix

Cardiovascular · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AstraZeneca · 1 shared drug class
Beijing Tiantan Hospital · 1 shared drug class
Chong Kun Dang Pharmaceutical · 1 shared drug class
Daewoong Pharmaceutical Co. LTD. · 1 shared drug class
Dong-A ST Co., Ltd. · 1 shared drug class
Gachon University Gil Medical Center · 1 shared drug class
Hanmi Pharmaceutical Company Limited · 1 shared drug class
Amgen · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Jung-min Ahn:

Cite this brief

Drug Landscape (2026). Jung-min Ahn — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/jung-min-ahn. Accessed 2026-06-10.